POLE and cancer: A recent study that analysed mutations in POLD and POLE from the cancer patient cohort in cBioPortal observed high levels of POLE/POLD1 mutations in several cancer types, including in 185 out of 2586 (7.2%) esophagogastric cancer samples [68].